Abstract:Background: Docosahexaenoic acid (DHA) and DHA-derived lipid mediators have recently been shown to possess anti-inflammatory and pro-resolving properties. In fact, DHA can down-regulate lipolysaccharide (LPS)-induced activation of NF-kappa B via a PPAR gamma-dependent pathway. We sought to investigate the effects of the novel DHA-derived mediator resolvin D1 (RvD1) on LPS-induced acute lung injury and to determine whether these effects occur via a PPAR gamma-dependent pathway.Methods: BALB/c mice aged 6-8 weeks were randomly divided into seven groups: two control groups receiving saline or RvD1 (600 ng) without LPS; a control group receiving LPS only; an experimental group receiving RvD1 (300 ng) or RvD1 (600 ng), followed by LPS; a group receiving the PPAR gamma antagonist GW9662; and a group receiving GW9662, then RvD1 (600 ng) and finally LPS. LPS (50 mu M) and saline were administered intratracheally. RvD1 was injected intravenously 24 h and 30 min before LPS, while GW9662 was injected intravenously 30 min before RvD1. Mice were killed at 6, 12, and 24 h. Samples of bronchoalveolar lavage fluid (BALF) were analyzed for cell counts and cytokine analysis. Lung tissues were collected for histology, Western blotting and electrophoretic mobility shift assays (EMSAs).Results: At all three time points, groups receiving either dose of RvD1 followed by LPS had significantly lower total leukocyte counts and levels of TNF-alpha and IL-6 levels in BALF than did the group given only LPS. RvD1 markedly attenuated LPS-induced lung inflammation at 24 h, based on hematoxylin-eosin staining of histology sections. RvD1 activated PPAR gamma and suppressed I kappa Ba degradation and NF-kappa B p65 nuclear translocation, based on Western blots and EMSAs. The PPAR gamma inhibitor GW9662 partially reversed RvD1-induced suppression of I kappa Ba degradation and p65 nuclear translocation.Conclusions: These results suggest that RvD1 may attenuate lung inflammation of LPS-induced acute lung injury by suppressing NF-kappa B activation through a mechanism partly dependent on PPAR gamma activation.

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and Its Analogue, 17R-Hydroxy-19-para-fluorophenoxy-resolvin D1 Methyl Ester, in C5a-Dependent IgG Immune Complex–Induced Inflammation and Lung Injury

E. coli peritonitis initiates D‐series Resolvin‐metabolome

Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

Resolvin D1 protects against sepsis‐induced cardiac injury in mice

Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway

Resolvin D1 Attenuates Inflammation In Lipopolysaccharide-Induced Acute Lung Injury Through A Process Involving The Ppar Gamma/Nf-Kappa B Pathway

Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo

Resolvin D1 (Rvd1) Attenuates In Vitro LPS-Stimulated Inflammation Through Downregulation of miR-155, miR -146, miR -148 and Krupple Like Factor 5

Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution

Inflammation resolution circuits are uncoupled in acute sepsis and correlate with clinical severity

Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner

Resolvin D1 Promotes SIRT1 Expression to Counteract the Activation of STAT3 and NF-κB in Mice with Septic-Associated Lung Injury

Resolvin D1 Protects Against Sepsis-Associated Encephalopathy in Mice by Inhibiting Neuro-Inflammation Induced by Microglia.

Resolvin D1 Attenuates Lung Inflammation in LPS Induced-Ali Partly Through PPARγ/NF-κB Pathway

RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages

Resolvins: Anti-Inflammatory and Proresolving Mediators Derived from Omega-3 Polyunsaturated Fatty Acids

Resolvin D1 Improves the Resolution of Inflammation via Activating NF-κB p50/p50-Mediated Cyclooxygenase-2 Expression in Acute Respiratory Distress Syndrome

Resolvins E1 and D1 in Choroid-Retinal Endothelial Cells and Leukocytes: Biosynthesis and Mechanisms of Anti-Inflammatory Actions.